Boiron SA banner

Boiron SA
PAR:BOI

Watchlist Manager
Boiron SA Logo
Boiron SA
PAR:BOI
Watchlist
Price: 25.85 EUR -0.58% Market Closed
Market Cap: €453.7m

Relative Value

The Relative Value of one BOI stock under the Base Case scenario is hidden EUR. Compared to the current market price of 25.85 EUR, Boiron SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BOI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

BOI Competitors Multiples
Boiron SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Boiron SA
PAR:BOI
448.8m EUR 0.9 23.2 5.5 14.8
US
Eli Lilly and Co
NYSE:LLY
869.6B USD 13.3 42.1 28.4 30.3
US
Johnson & Johnson
NYSE:JNJ
574.6B USD 6.1 21.4 14.9 18.3
CH
Roche Holding AG
SIX:ROG
250.6B CHF 4.1 19.5 11.5 13
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP 5 28.6 15.9 22.4
CH
Novartis AG
SIX:NOVN
225.9B CHF 5.2 20.8 12.9 16.5
US
Merck & Co Inc
NYSE:MRK
282.7B USD 4.3 15.5 9.6 11.7
IE
Endo International PLC
LSE:0Y5F
240.1B USD 103.6 -82.1 380.1 953.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.4 10.3 7.7 9
US
Pfizer Inc
NYSE:PFE
156.1B USD 2.5 20.1 7.7 10.3
US
Bristol-Myers Squibb Co
NYSE:BMY
117.7B USD 2.4 16.7 7.1 8.7
P/E Multiple
Earnings Growth PEG
FR
Boiron SA
PAR:BOI
Average P/E: 21.8
23.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
42.1
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
21.4
7%
3.1
CH
Roche Holding AG
SIX:ROG
19.5
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
28.6
26%
1.1
CH
Novartis AG
SIX:NOVN
20.8
14%
1.5
US
Merck & Co Inc
NYSE:MRK
15.5
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -82.1 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.3
1%
10.3
US
Pfizer Inc
NYSE:PFE
20.1
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
16.7
16%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Boiron SA
PAR:BOI
Average EV/EBITDA: 45.6
5.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
28.4
22%
1.3
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.4
CH
Roche Holding AG
SIX:ROG
11.5
6%
1.9
UK
AstraZeneca PLC
LSE:AZN
15.9
13%
1.2
CH
Novartis AG
SIX:NOVN
12.9
5%
2.6
US
Merck & Co Inc
NYSE:MRK
9.6
3%
3.2
IE
E
Endo International PLC
LSE:0Y5F
380.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.7
1%
7.7
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.1
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Boiron SA
PAR:BOI
Average EV/EBIT: 100.7
14.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
30.3
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
18.3
7%
2.6
CH
Roche Holding AG
SIX:ROG
13
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
22.4
21%
1.1
CH
Novartis AG
SIX:NOVN
16.5
9%
1.8
US
Merck & Co Inc
NYSE:MRK
11.7
6%
2
IE
E
Endo International PLC
LSE:0Y5F
953.2
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9
3%
3
US
Pfizer Inc
NYSE:PFE
10.3
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.7
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett